- Published at
- by zacks.com
positive
positive
Surface Oncology, Inc. (SURF) to Report Q4 Results: Wall Street Expects Earnings Growth
Surface Oncology, Inc. (SURF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.